HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial.

AbstractOBJECTIVE:
To assess whether daily gentamicin is as effective as 8-hour gentamicin for the treatment of intrapartum chorioamnionitis.
METHODS:
Women with a clinical diagnosis of chorioamnionitis between 32 and 42 weeks of gestation were randomly assigned in labor to receive either daily gentamicin (5 mg/kg intravenously (IV), then 2 placebo doses IV after 8 and 16 hours) or 8-hour gentamicin (2 mg/kg IV, then 1.5 mg/kg IV after 8 and 16 hours). Both groups received ampicillin (2 grams IV every 6 hours for a total of four doses). Patients who underwent cesarean delivery also received clindamycin (900 mg IV every 8 hours, for a total of three doses). The primary outcome was treatment success, defined by resolution of chorioamnionitis after 16 hours of treatment without development of endometritis. One hundred twenty-six patients were required to have 95% confidence that daily gentamicin is at worst 15% inferior to 8-hour dosing with an alpha of .05 and a beta of 0.2.
RESULTS:
One hundred twenty-six women were enrolled, of whom 63 received daily gentamicin and 63 received 8-hour gentamicin. One patient was excluded from data analysis. Baseline maternal and obstetric characteristics were similar between groups except for longer mean duration of ruptured membranes in the 8-hour group (679+/-514 compared with 469+/-319 minutes; P =.03). Treatment success was equal between groups (94% daily gentamicin compared with 89% 8-hour gentamicin, P =.53). There were no differences in maternal or neonatal morbidities, including neonatal sepsis and newborn hearing screen.
CONCLUSION:
Daily and 8-hour gentamicin appear equally effective for the treatment of intrapartum chorioamnionitis.
CLINICAL TRIAL REGISTRATION:
ClinicalTrials.gov, www.clinicaltrials.gov, NCT00185991.
LEVEL OF EVIDENCE:
I.
AuthorsDeirdre J Lyell, Kristin Pullen, Katherine Fuh, A Musa Zamah, Aaron B Caughey, William Benitz, Yasser Y El-Sayed
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 115 Issue 2 Pt 1 Pg. 344-349 (Feb 2010) ISSN: 1873-233X [Electronic] United States
PMID20093909 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Gentamicins
Topics
  • Adult
  • Anti-Bacterial Agents (administration & dosage)
  • Chorioamnionitis (drug therapy)
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Fetal Membranes, Premature Rupture
  • Gentamicins (administration & dosage)
  • Humans
  • Injections, Intravenous
  • Pregnancy
  • Pregnancy Trimester, Third

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: